Cell Therapy Production Automation Set To Be On The Horizon
In a recent move, Multiply Labs and Thermo Fisher Scientific have gone ahead and inked a deal in order to expand their partnership and...
Medicines For Europe Calls Simpler SPC Manufacturing Waiver
As per Medicines for Europe, the Munich District Court’s Supplementary Protection Certificate- SPC manufacturing waiver, which was issued in Germany in October last year,...
2.8 Billion Dollars Projection By 2031 For CGT Manufacturing
As per a report from Transparency Market Research Inc., the global market for quality control in the manufacturing of CGT (cell and gene therapies)...
AAV Gene Therapy CDMOs Shaping The Future With A $2.57B Goal
The global market for cell and gene therapy biomanufacturing Contract Development and Manufacturing Organizations (CDMOs), with a specific focus on Adeno-Associated Virus (AAV), witnessed...
Biologics And Regulations Propel Aseptic Fill-Finish Growth
Projected data suggests that the global expenditure on medications will reach $1.29 trillion by 2027(i). This surge in spending has led to a heightened...
Advancing Biopharmaceuticals With Novel Drug Modalities
The biopharmaceutical sector is undergoing a significant transformation in treating complex diseases, especially in oncology, driven by innovative drug approaches. This shift entails personalized...
Rising Analytics Use Shapes Pharmaceutical CDMO Industry
According to insights, the pharmaceutical CDMO market is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.29% until 2028. This growth...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...